日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Comparison of in silico predictions of action potential duration in response to inhibition of IKr and ICaL with new human ex vivo recordings

将计算机模拟预测的抑制 IKr 和 ICaL 后动作电位持续时间与新的人体离体记录进行比较

Barral, Yann-Stanislas H M; Polonchuk, Liudmila; Clerx, Michael; Gavaghan, David J; Mirams, Gary R; Wang, Ken

Models of the cardiac L-type calcium current: A quantitative review

心脏L型钙电流模型:定量综述

Agrawal, Aditi; Wang, Ken; Polonchuk, Liudmila; Cooper, Jonathan; Hendrix, Maurice; Gavaghan, David J; Mirams, Gary R; Clerx, Michael

A model-informed approach to assess the risk of immune checkpoint inhibitor-induced autoimmune myocarditis

基于模型的方法评估免疫检查点抑制剂诱发自身免疫性心肌炎的风险

van der Vegt, Solveig A; Wang, Ying-Jie; Polonchuk, Liudmila; Wang, Ken; Waters, Sarah L; Baker, Ruth E

Current state and future of 3D bioprinted models for cardiovascular research and drug development

3D生物打印模型在心血管研究和药物开发中的现状与未来

Polonchuk, Liudmila; Gentile, Carmine

Cardiac Safety of Kinase Inhibitors - Improving Understanding and Prediction of Liabilities in Drug Discovery Using Human Stem Cell-Derived Models

激酶抑制剂的心脏安全性 - 利用人类干细胞衍生模型提高对药物发现中责任的理解和预测

Ricarda Ziegler, Fabian Häusermann, Stephan Kirchner, Liudmila Polonchuk

Use of Patient Health Records to Quantify Drug-Related Pro-arrhythmic Risk

使用患者健康记录来量化药物相关的心律失常风险

Mark R Davies, Michael Martinec, Robert Walls, Roman Schwarz, Gary R Mirams, Ken Wang, Guido Steiner, Andy Surinach, Carlos Flores, Thierry Lavé, Thomas Singer, Liudmila Polonchuk

General Principles for the Validation of Proarrhythmia Risk Prediction Models: An Extension of the CiPA In Silico Strategy

心律失常风险预测模型验证的一般原则:CiPA 计算机模拟策略的扩展

Li, Zhihua; Mirams, Gary R; Yoshinaga, Takashi; Ridder, Bradley J; Han, Xiaomei; Chen, Janell E; Stockbridge, Norman L; Wisialowski, Todd A; Damiano, Bruce; Severi, Stefano; Morissette, Pierre; Kowey, Peter R; Holbrook, Mark; Smith, Godfrey; Rasmusson, Randall L; Liu, Michael; Song, Zhen; Qu, Zhilin; Leishman, Derek J; Steidl-Nichols, Jill; Rodriguez, Blanca; Bueno-Orovio, Alfonso; Zhou, Xin; Passini, Elisa; Edwards, Andrew G; Morotti, Stefano; Ni, Haibo; Grandi, Eleonora; Clancy, Colleen E; Vandenberg, Jamie; Hill, Adam; Nakamura, Mikiko; Singer, Thomas; Polonchuk, Liudmila; Greiter-Wilke, Andrea; Wang, Ken; Nave, Stephane; Fullerton, Aaron; Sobie, Eric A; Paci, Michelangelo; Musuamba Tshinanu, Flora; Strauss, David G

Cross-site and cross-platform variability of automated patch clamp assessments of drug effects on human cardiac currents in recombinant cells.

药物对重组细胞中人类心脏电流影响的自动膜片钳评估的跨站点和跨平台变异性

Kramer James, Himmel Herbert M, Lindqvist Anders, Stoelzle-Feix Sonja, Chaudhary Khuram W, Li Dingzhou, Bohme Georg Andrees, Bridgland-Taylor Matthew, Hebeisen Simon, Fan Jingsong, Renganathan Muthukrishnan, Imredy John, Humphries Edward S A, Brinkwirth Nina, Strassmaier Tim, Ohtsuki Atsushi, Danker Timm, Vanoye Carlos, Polonchuk Liudmila, Fermini Bernard, Pierson Jennifer Beck, Gintant Gary

Corrigendum to "A systematic strategy for estimating hERG block potency and its implications in a new cardiac safety paradigm" [Toxicology and Applied Pharmacology volume 394C (2020) 114961]

对“评估 hERG 阻滞效力的系统策略及其在新的心脏安全范式中的意义”的更正[毒理学和应用药理学卷 394C (2020) 114961]

Ridder, Bradley J; Leishman, Derek J; Bridgland-Taylor, Matthew; Samieegohar, Mohammadreza; Han, Xiaomei; Wu, Wendy W; Randolph, Aaron; Tran, Phu; Sheng, Jiansong; Danker, Timm; Lindqvist, Anders; Konrad, Daniel; Hebeisen, Simon; Polonchuk, Liudmila; Gissinger, Evgenia; Renganathan, Muthukrishnan; Koci, Bryan; Wei, Haiyang; Fan, Jingsong; Levesque, Paul; Kwagh, Jae; Imredy, John; Zhai, Jin; Rogers, Marc; Humphries, Edward; Kirby, Robert; Stoelzle-Feix, Sonja; Brinkwirth, Nina; Rotordam, Maria Giustina; Becker, Nadine; Friis, Søren; Rapedius, Markus; Goetze, Tom A; Strassmaier, Tim; Okeyo, George; Kramer, James; Kuryshev, Yuri; Wu, Caiyun; Himmel, Herbert; Mirams, Gary R; Strauss, David G; Bardenet, Remi; Li, Zhihua

A systematic strategy for estimating hERG block potency and its implications in a new cardiac safety paradigm.

评估 hERG 阻滞效力的系统策略及其在新心脏安全范式中的意义

Ridder Bradley J, Leishman Derek J, Bridgland-Taylor Matthew, Samieegohar Mohammadreza, Han Xiaomei, Wu Wendy W, Randolph Aaron, Tran Phu, Sheng Jiansong, Danker Timm, Lindqvist Anders, Konrad Daniel, Hebeisen Simon, Polonchuk Liudmila, Gissinger Evgenia, Renganathan Muthukrishnan, Koci Bryan, Wei Haiyang, Fan Jingsong, Levesque Paul, Kwagh Jae, Imredy John, Zhai Jin, Rogers Marc, Humphries Edward, Kirby Robert, Stoelzle-Feix Sonja, Brinkwirth Nina, Rotordam Maria Giustina, Becker Nadine, Friis Søren, Rapedius Markus, Goetze Tom A, Strassmaier Tim, Okeyo George, Kramer James, Kuryshev Yuri, Wu Caiyun, Himmel Herbert, Mirams Gary R, Strauss David G, Bardenet Rémi, Li Zhihua